“But we should be able to show them there's something better.”.
While there, he engaged Bryden Wood and together they developed the Front End Factory, a collaborative endeavour to explore how to turn purpose and strategy into the right projects – which paved the way for Design to Value.He is committed to the betterment of lives through individual and collective endeavours.. As well as his business and pharmaceutical experience, Dyson is Professor of Human Enterprise at the University of Birmingham, focussing on project management, business strategy and collaboration.. Additionally, he is a qualified counsellor with a private practice and looks to bring the understanding of human behaviour into business and projects.. To learn more about our Design to Value philosophy, read Design to Value: The architecture of holistic design and creative technology by Professor John Dyson, Mark Bryden, Jaimie Johnston MBE and Martin Wood.
Available to purchase at.'Transforming Small Molecule API Manufacturing' explores the innovative strides being made towards more efficient, sustainable, and cost-effective drug production.. Adrian La Porta.shares his insights on the pivotal role of miniaturisation and automation in shaping the future of Active Pharmaceutical Ingredients (APIs) production, highlighting the potential for significant industry transformation.. Watch now for a unique perspective on how modern advancements are paving the way for a new era in pharmaceuticals, not only redefining manufacturing processes but also promising a healthier future for all.Presented by our Head of Sustainability, Helen Hough, this video takes you on a journey through the development of The Forge, a landmark London project that represents a significant leap in sustainable construction..Discover the pioneering use of a platforms approach to Design for Manufacture and Assembly (P-DfMA) and how it contributed to a remarkable reduction in whole-life carbon emissions..
Through Helen's expert insights, learn about the collaborative efforts and innovative strategies that make The Forge a model for future construction projects aiming for environmental excellence.Through this 'In Short' episode,.delves into the challenges and breakthroughs in pharmaceutical manufacturing, exploring how new approaches like process intensification, automation, and continuous processing can lead to more agile, cost-effective, and environmentally friendly production methods.. Click the 'play button' above to listen in, or read our 5 Key Takeaways from this episode below.... 1.
Revolution in small molecule API production:.
The episode highlights the transformative research and development in small molecule Active Pharmaceutical Ingredients, emphasising the generation of new, more complex, and targeted molecules.Johnston feels that the adoption of a more standardised, foundational approach will act as a springboard, setting up the opportunity to work with more sophisticated industrialised construction techniques like prefab and DfMA.. Amy Marks is fine with the idea of standardisation but thinks things also depend on how performance-based, or prescriptive those standards are.
She cautions that we don’t want a level of standardisation where there isn’t space for innovation, or which “precludes fabrication.”.These things really depend on who makes the standards, she says, what they are thinking of enabling in the future, and what their understanding of the future looks like.
Not all policymakers are thinking about industrialised construction, prefabrication, or DfMA.They may be looking at things in terms of one particular market application, but not in terms of others.